Informatie:
Fout:
ID
28007
Beschrijving
Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients; ODM derived from: https://clinicaltrials.gov/show/NCT00889629
Link
https://clinicaltrials.gov/show/NCT00889629
Trefwoorden
Versies (1)
- 09-12-17 09-12-17 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
9 december 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Chronic Kidney Disease NCT00889629
Eligibility Chronic Kidney Disease NCT00889629
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Kidney Disease NCT00889629
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Adult | Age
Item
adults of both genders between the ages of 18 and 65.
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Kidney Transplantation
Item
kidney transplant at least 1 year prior to enrollment
boolean
C0022671 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine value of <2.5 mg/dl with no excursion >0.5 within the past 3 months
boolean
C0201976 (UMLS CUI [1])
Proteinuria | Protein to Creatinine Ratio Measurement
Item
proteinuria of 500 mg/24 hours or a protein/creatinine ratio of 0.5 or greater
boolean
C0033687 (UMLS CUI [1])
C0428627 (UMLS CUI [2])
C0428627 (UMLS CUI [2])
Vitamin D Deficiency | Low 25-OH-vitamin D level
Item
hypovitaminosis d, as defined by a 25-oh vitamin d value of <25 ng/ml
boolean
C0042870 (UMLS CUI [1])
C3279609 (UMLS CUI [2])
C3279609 (UMLS CUI [2])
serum intact PTH level
Item
intact pth value between 150 and 600 pg/ml
boolean
C2041365 (UMLS CUI [1])
Parathyroidectomy
Item
history of parathyroidectomy
boolean
C0079989 (UMLS CUI [1])
Intolerance to Vitamin D | Exception Hypercalcemia
Item
history of prior intolerance to vitamin d therapy (not including hypercalcemia)
boolean
C1744706 (UMLS CUI [1,1])
C0042866 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0020437 (UMLS CUI [2,2])
C0042866 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0020437 (UMLS CUI [2,2])
Rejection Biopsy
Item
history of biopsy proven acute rejection over the 3 months preceding enrollment
boolean
C0018129 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin
Item
recent (over the past month) addition of an ace inhibitor or angiotensin -
boolean
C0003015 (UMLS CUI [1])
C0003018 (UMLS CUI [2])
C0003018 (UMLS CUI [2])
Beta adrenergic receptor blocking agent
Item
receptor blocking agent - patients who have been on a stable dose are acceptable
boolean
C2585032 (UMLS CUI [1])
Vitamin D supplement
Item
current use of active vitamin d supplement (patients in whom therapy has been discontinued more than 1 month prior to enrollment are acceptable)
boolean
C3541352 (UMLS CUI [1])
Postmenopausal state | Gender Hormone replacement therapy
Item
postmenopausal woman or women receiving hormone replacement therapy
boolean
C0232970 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0282402 (UMLS CUI [2,2])
C0079399 (UMLS CUI [2,1])
C0282402 (UMLS CUI [2,2])